Bioinformatic analysis of the clinicopathological and prognostic significance of oocyte-arresting BTG4 mRNA expression in gynecological cancers

References

• Alves Pinto de Andrade, D., et al., 2022. Reassessment of low- and intermediate-risk endometrial cancer reports by gynecological pathologists increases risk classification without impacting outcome. The European Journal of Obstetrics & Gynecology and Reproductive Biology, 278, 172–176.
   PubMed Web of Science ®Google Scholar
• Auer, R.L., et al., 2005. Identification of a potential role for POU2AF1 and BTG4 in the deletion of 11q23 in chronic lymphocytic leukemia. Genes, Chromosomes & Cancer, 43 (1), 1–10.
   PubMed Web of Science ®Google Scholar
• Börner, C., et al., 2018. Pain mechanisms in peritoneal diseases might be partially regulated by estrogen. Reproductive Sciences, 25 (3), 424–434.
   PubMed Web of Science ®Google Scholar
• Buanne, P., et al., 2000. Cloning of PC3B, a novel member of the PC3/BTG/TOB family of growth inhibitory genes, highly expressed in the olfactory epithelium. Genomics, 68 (3), 253–263.
   PubMed Web of Science ®Google Scholar
• Chu, T., et al., 2012. Effect of ovarian stimulation on oocyte gene expression in cattle. Theriogenology, 77 (9), 1928–1938.
   PubMed Web of Science ®Google Scholar
• Dellino, M., et al., 2021. A strengthening the reporting of observational studies in epidemiology (STROBE): are HE4 and CA 125 suitable to detect a Paget disease of the vulva? Medicine, 100 (5), e24485.
   PubMed Web of Science ®Google Scholar
• Dong, W., et al., 2009. Frequent promoter hypermethylation and transcriptional downregulation of BTG4 gene in gastric cancer. Biochemical and Biophysical Research Communications, 387 (1), 132–138.
   PubMed Web of Science ®Google Scholar
• Elis, S., et al., 2008. Search for the genes involved in oocyte maturation and early embryo development in the hen. BMC Genomics., 9, 110.
   PubMed Web of Science ®Google Scholar
• Fagotti, A., et al., 2020. Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850). International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society, 30 (11), 1657–1664.
   PubMed Web of Science ®Google Scholar
• Giannini, A., et al., 2022. Advances on prevention and screening of gynecologic tumors, are we stepping forward? Healthcare, 10 (9), 1605.
   Web of Science ®Google Scholar
• Khoramdad, M., et al., 2022. Breast cancer risk factors in Iranian women: a systematic review and meta-analysis of matched case-control studies. European Journal of Medical Research, 27 (1), 311.
   PubMed Web of Science ®Google Scholar
• Králíčková, M., et al., 2020. Endometriosis and risk of ovarian cancer: what do we know? Archives of Gynecology and Obstetrics, 301 (1), 1–10.
   PubMed Web of Science ®Google Scholar
• Laganà, A.S., et al., 2015. Cytogenetic analysis of epithelial ovarian cancer’s stem cells: an overview on new diagnostic and therapeutic perspectives. European Journal of Gynaecological Oncology, 36 (5), 495–505.
   PubMed Web of Science ®Google Scholar
• Laganà, A.S., et al., 2016. Epithelial ovarian cancer inherent resistance: may the pleiotropic interaction between reduced immunosurveillance and drug-resistant cells play a key role? Gynecologic Oncology Reports, 18, 57–58.
   PubMed Web of Science ®Google Scholar
• Li, Y., et al., 2022. MSLN correlates with immune infiltration and chemoresistance as a prognostic biomarker in ovarian cancer. Frontiers in Oncology, 12, 830570.
   PubMed Web of Science ®Google Scholar
• Liu, R., et al., 2021. A novel homozygous missense variant in BTG4 causes zygotic cleavage failure and female infertility. Journal of Assisted Reproduction and Genetics, 38 (12), 3261–3266.
   PubMed Web of Science ®Google Scholar
• Liu, Y., et al., 2016. BTG4 is a key regulator for maternal mRNA clearance during mouse early embryogenesis. Journal of Molecular Cell Biology, 8 (4), 366–368.
   PubMed Web of Science ®Google Scholar
• Mano, H., et al., 2015. Age-related decrease of IF5/BTG4 in oral and respiratory cavities in mice. Bioscience, Biotechnology, and Biochemistry, 79 (6), 960–968.
   PubMed Web of Science ®Google Scholar
• Mori, Y., et al., 2011. Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning. Endocrine-Related Cancer, 18 (4), 465–478.
   PubMed Web of Science ®Google Scholar
• Mulongo, M., et al., 2022. Prevention of cervical cancer in low-resource African settings. Obstetrics and Gynecology Clinics of North America, 49 (4), 771–781.
   PubMed Web of Science ®Google Scholar
• Pasternak, M., et al., 2016. The BTG4 and CAF1 complex prevents the spontaneous activation of eggs by deadenylating maternal mRNAs. Open Biology, 6 (9), 160184.
   PubMed Web of Science ®Google Scholar
• Pennetier, S., et al., 2005. Genes preferentially expressed in bovine oocytes revealed by subtractive and suppressive hybridization. Biology of Reproduction, 73 (4), 713–720.
   PubMed Web of Science ®Google Scholar
• Räty, M., et al., 2011. In vitro maturation supplements affect developmental competence of bovine cumulus-oocyte complexes and embryo quality after vitrification. Cryobiology, 63 (3), 245–255.
   PubMed Web of Science ®Google Scholar
• Seo, J.S., et al., 2017. Hinokitiol induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer cells. BMC Molecular and Cell Biology, 18 (1), 14.
   Google Scholar
• Szász, A.M., et al., 2016. Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget, 7 (31), 49322–49333.
   PubMedGoogle Scholar
• Toyota, M., et al., 2008. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Research, 68 (11), 4123–4132.
   PubMed Web of Science ®Google Scholar
• Winkler, G.S., 2010. The mammalian anti-proliferative BTG/Tob protein family. Journal of Cellular Physiology, 222 (1), 66–72.
   PubMed Web of Science ®Google Scholar
• Yu, C., et al., 2016. BTG4 is a meiotic cell cycle-coupled maternal-zygotic-transition licensing factor in oocytes. Nature Structural & Molecular Biology, 23 (5), 387–394.
   PubMed Web of Science ®Google Scholar
• Zhang, N., et al., 2020. BTG4 is a novel p53 target gene that inhibits cell growth and induces apoptosis. Genes (Basel), 11 (2), 217.
   PubMed Web of Science ®Google Scholar
• Zheng, W., et al., 2020. Homozygous mutations in BTG4 cause zygotic cleavage failure and female infertility. American Journal of Human Genetics, 107 (1), 24–33.
   PubMed Web of Science ®Google Scholar
• Zhu, Y., et al., 2014. TCGA-assembler: open-source software for retrieving and processing TCGA data. Nature Methods, 11 (6), 599–600.
   PubMed Web of Science ®Google Scholar